Fulgent Genetics IncNASDAQ:FLGT
- LAST PRICE17.8500
- TODAY'S CHANGE (%)-0.4800 (-2.6187%)
- Bid / Lots17.8100/ 6
- Ask / Lots17.8900/ 6
- Open / Previous Close18.1700 / 18.3300
- Day Range
- 52 Week Range
- Volume37,391
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | FLGT |
|---|---|---|
| 09:32 ET | 5023 | 18.12 |
| 09:39 ET | 350 | 18.12 |
| 09:44 ET | 3645 | 17.8761 |
| 09:46 ET | 685 | 17.91 |
| 09:51 ET | 128 | 17.835 |
| 09:55 ET | 530 | 17.78 |
| 09:57 ET | 853 | 17.8999 |
| 10:00 ET | 700 | 17.75 |
| 10:02 ET | 1457 | 17.8 |
| 10:06 ET | 146 | 17.8 |
| 10:08 ET | 295 | 17.75 |
| 10:13 ET | 1626 | 17.9 |
| 10:18 ET | 400 | 17.91 |
| 10:20 ET | 100 | 17.94 |
| 10:24 ET | 490 | 17.96 |
| 10:26 ET | 311 | 17.85 |
| 10:31 ET | 1100 | 17.93 |
| 10:33 ET | 100 | 17.925 |
| 10:36 ET | 7080 | 17.83 |
| 10:38 ET | 908 | 17.7 |
| 10:40 ET | 471 | 17.74 |
| 10:44 ET | 300 | 17.75 |
| 10:47 ET | 150 | 17.6968 |
| 10:49 ET | 1200 | 17.72 |
| 10:54 ET | 622 | 17.75 |
| 10:56 ET | 100 | 17.82 |
| 11:02 ET | 100 | 17.8 |
| 11:03 ET | 100 | 17.87 |
| 11:05 ET | 100 | 17.85 |
Nov 11, 2024
DJ Fulgent Genetics Is Maintained at Neutral by Piper Sandler, from 8:05AM ET on Monday Nov 11, 2024 by Dow Jones
8:05AM ET on Monday Nov 11, 2024 by Dow Jones
Nov 8, 2024
Fulgent Reports Third Quarter 2024 Financial Results, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
7:00AM ET on Friday Nov 08, 2024 by Dow Jones*DJ Fulgent Genetics 3Q Loss/Shr 48c >FLGT, from 7:00AM ET on Friday Nov 08, 2024 by Dow Jones
7:00AM ET on Friday Nov 08, 2024 by Dow Jones
Nov 5, 2024
Fulgent to Participate in Upcoming Conferences, from 8:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
8:00AM ET on Tuesday Nov 05, 2024 by Dow Jones
Oct 31, 2024
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Fulgent Genetics Inc | 546.6M | -3.2x | --- |
Sonida Senior Living Inc | 473.5M | -11.8x | --- |
Talkspace Inc | 582.8M | -402.2x | --- |
Global Medical REIT Inc | 581.2M | -410.3x | -8.35% |
Universal Health Realty Income Trust | 563.0M | 31.8x | -8.76% |
Community Healthcare Trust Inc | 523.0M | -159.3x | +1.34% |
Company Information
Fulgent Genetics, Inc. is a technology-based genetic company with a laboratory services business and a therapeutic development business. The Company’s laboratory services business includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a range of cancers using a nanoencapsulation and targeted therapy platform designed to improve the therapeutic window and pharmacokinetic profile (PK) profile of new and existing cancer drugs. Its technology platform for its laboratory services business includes gene probes, data suppression and comparison algorithms, learning software, and laboratory information management systems. The platform provides a test menu, the ability to rapidly develop and launch new tests and customizable test offerings. The Company also offers next-generation sequencing (NGS) services.
Contact Information
- Headquarters
- 4399 SANTA ANITA AVEEL MONTE, CA, United States 91731
- Phone
- 626-350-0537
- Fax
- 626-454-1667
Executives
- Chairman of the Board, Chief Executive Officer
- Ming Hsieh
- President, Chief Operating Officer
- Jian Xie
- Chief Financial Officer
- Paul Kim
- Chief Scientific Officer, Laboratory Director
- Hanlin Gao
- Independent Director
- Regina Groves
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $546.6M |
|---|---|
Revenue (TTM) | $277.8M |
Shares Outstanding | 30.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-5.53 |
Book Value | $38.31 |
P/E Ratio | -3.2x |
Price/Sales (TTM) | 2.0 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -78.84% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
